89 related articles for article (PubMed ID: 19517475)
1. Correlative analysis of gene expression profile and prognosis in patients with gliomatosis cerebri.
D'Urso OF; D'Urso PI; Marsigliante S; Storelli C; Luzi G; Gianfreda CD; Montinaro A; Distante A; Ciappetta P
Cancer; 2009 Aug; 115(16):3749-57. PubMed ID: 19517475
[TBL] [Abstract][Full Text] [Related]
2. Gliomatosis cerebri: molecular pathology and clinical course.
Herrlinger U; Felsberg J; Küker W; Bornemann A; Plasswilm L; Knobbe CB; Strik H; Wick W; Meyermann R; Dichgans J; Bamberg M; Reifenberger G; Weller M
Ann Neurol; 2002 Oct; 52(4):390-9. PubMed ID: 12325066
[TBL] [Abstract][Full Text] [Related]
3. [Gliomatosis cerebri].
Masuoka J; Tabuchi K
Nihon Rinsho; 2005 Sep; 63 Suppl 9():128-32. PubMed ID: 16201512
[No Abstract] [Full Text] [Related]
4. Pediatric Gliomatosis Cerebri: A Review of 15 Years.
George E; Settler A; Connors S; Greenfield JP
J Child Neurol; 2016 Mar; 31(3):378-87. PubMed ID: 26239491
[TBL] [Abstract][Full Text] [Related]
5. Gliomatosis cerebri: Prognosis based on current molecular markers.
Maharaj MM; Phan K; Xu J; Fairhall J; Reddy R; Rao PJV
J Clin Neurosci; 2017 Sep; 43():1-5. PubMed ID: 28539209
[TBL] [Abstract][Full Text] [Related]
6. Histological and genetic diagnosis of gliomatosis cerebri: case report.
Yamada SM; Hayashi Y; Takahashi H; Teramoto A; Matsumoto K; Yamada S
J Neurooncol; 2001 May; 52(3):237-40. PubMed ID: 11519853
[TBL] [Abstract][Full Text] [Related]
7. Analysis of TP53 and PTEN in gliomatosis cerebri.
Mawrin C; Kirches E; Schneider-Stock R; Scherlach C; Vorwerk C; Von Deimling A; Van Landeghem F; Meyermann R; Bornemann A; Müller A; Romeike B; Stoltenburg-Didinger G; Wickboldt J; Pilz P; Dietzmann K
Acta Neuropathol; 2003 Jun; 105(6):529-36. PubMed ID: 12734658
[TBL] [Abstract][Full Text] [Related]
8. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic alterations in gliomatosis cerebri: what can we learn about the origin and course of the disease?
Mawrin C
Acta Neuropathol; 2005 Dec; 110(6):527-36. PubMed ID: 16222524
[TBL] [Abstract][Full Text] [Related]
10. Genetic aberrations in gliomatosis cerebri.
Ware ML; Hirose Y; Scheithauer BW; Yeh RF; Mayo MC; Smith JS; Chang S; Cha S; Tihan T; Feuerstein BG
Neurosurgery; 2007 Jan; 60(1):150-8; discussion 158. PubMed ID: 17228264
[TBL] [Abstract][Full Text] [Related]
11. Distribution of p53 alterations in a case of gliomatosis cerebri.
Mawrin C; Lins H; Kirches E; Schildhaus HU; Scherlach C; Kanakis D; Dietzmann K
Hum Pathol; 2003 Jan; 34(1):102-6. PubMed ID: 12605375
[TBL] [Abstract][Full Text] [Related]
12. IDH1 mutation, a genetic alteration associated with adult gliomatosis cerebri.
Narasimhaiah D; Miquel C; Verhamme E; Desclée P; Cosnard G; Godfraind C
Neuropathology; 2012 Feb; 32(1):30-7. PubMed ID: 21481010
[TBL] [Abstract][Full Text] [Related]
13. Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis.
Kros JM; Zheng P; Dinjens WN; Alers JC
J Neuropathol Exp Neurol; 2002 Sep; 61(9):806-14. PubMed ID: 12230327
[TBL] [Abstract][Full Text] [Related]
14. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
Seiz M; Tuettenberg J; Meyer J; Essig M; Schmieder K; Mawrin C; von Deimling A; Hartmann C
Acta Neuropathol; 2010 Aug; 120(2):261-7. PubMed ID: 20514489
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of gliomas strongly predicts survival.
Freije WA; Castro-Vargas FE; Fang Z; Horvath S; Cloughesy T; Liau LM; Mischel PS; Nelson SF
Cancer Res; 2004 Sep; 64(18):6503-10. PubMed ID: 15374961
[TBL] [Abstract][Full Text] [Related]
16. Gliomatosis cerebri: clinical characteristics, management, and outcomes.
Chen S; Tanaka S; Giannini C; Morris J; Yan ES; Buckner J; Lachance DH; Parney IF
J Neurooncol; 2013 Apr; 112(2):267-75. PubMed ID: 23341100
[TBL] [Abstract][Full Text] [Related]
17. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
[TBL] [Abstract][Full Text] [Related]
18. Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.
Taillibert S; Chodkiewicz C; Laigle-Donadey F; Napolitano M; Cartalat-Carel S; Sanson M
J Neurooncol; 2006 Jan; 76(2):201-5. PubMed ID: 16200347
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profile as a prognostic factor in high-grade gliomas.
Czernicki T; Zegarska J; Paczek L; Cukrowska B; Grajkowska W; Zajaczkowska A; Brudzewski K; Ulaczyk J; Marchel A
Int J Oncol; 2007 Jan; 30(1):55-64. PubMed ID: 17143512
[TBL] [Abstract][Full Text] [Related]
20. Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study.
Ly KI; Oakley DH; Pine AB; Frosch MP; Chiou SH; Betensky RA; Pomerantz SR; Hochberg FH; Batchelor TT; Cahill DP; Dietrich J
Oncologist; 2019 Mar; 24(3):402-413. PubMed ID: 30097523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
